期刊文献+

硒和锌对细胞氧化低密度脂蛋白作用的影响 被引量:1

Effect of Na_2SeO_3 and ZnSO_4 on Oxidation Modification of Human Low Density Lipoprotein
下载PDF
导出
摘要 为探讨微量元素硒和锌在体内抗低密度脂蛋白氧化的作用及其可能机制 ,采用硫代巴比妥酸法测定大鼠动脉平滑肌细胞对低密度脂蛋白的氧化反应 ,采用噻唑蓝法了解动脉平滑肌细胞增殖及邻联二茴香胺底物反应的方法测髓过氧化物酶活性。结果表明 10 μmol/L亚硒酸钠显著减少了丙二醛的生成 ,而相同浓度的硫酸锌效应不明显 ,但二者均可见动脉平滑肌细胞增殖减少。此外 ,低密度脂蛋白诱导动脉平滑肌细胞的髓过氧化物酶活性显著升高 ,但 10 μmol/L亚硒酸钠似乎不能抑制这种效应。提示硒与锌均抑制氧化型低密度脂蛋白促动脉平滑肌细胞的增殖作用 ,前者与抗低密度脂蛋白氧化有关 ,且可能发生在髓过氧化物酶催化形成酪酰基自由基之后的某个环节 ,后者尚待进一步探讨。 Aim The antioxidation effect of Na 2SeO 3 and ZnSO 4, on the oxidation of human low density lipoprotein(LDL) were investigated by rat's arterial smooth muscle cells(ASMC). Methods Oxidation of LDL was induced by rat's ASMC added 1 μmol/L Cu 2+ . The extent of LDL modification was assessed by measuring the formation of thiobarbituric acid reactive substance(TBARS). Results Treatment of 10 μmol/L Na 2SeO 3 and ZnSO 4 inhibited ASMC proliferation by ox-LDL(P<0.01). Treatment of 10 μmol/L Na 2SeO 3 inhibited MDA production(P<0.01), but 10 μmol/L ZnSO 4 have no the effect. 50 mg/L LDL induced myoleperoxidase(MPO) activity, but 10 μmol/L Na 2SeO 3 can not inhitit the effect. Conclusion 10 μmol/L Na 2SeO 3 could protect LDL against rat's ASMC inducing oxidation modification in vitro, which might be contributed by its effect to tyrosyl radical generated by myoleperoxidase.
出处 《中国动脉硬化杂志》 CAS CSCD 2000年第4期327-329,共3页 Chinese Journal of Arteriosclerosis
关键词 亚硒酸钠 硫酸锌 低密度脂蛋白 髓过氧化物酶 Na 2SeO 3 ZnSO 4 Lipoprotein, LDL Thiobarbituric Acid Reactive Substance Myoleperoxid4
  • 相关文献

参考文献7

  • 1赵三妹 夏人仪.动脉平滑肌细胞的培养方法及其应用[J].中华病理学杂志,1987,16:260-260.
  • 2张爱元,杨国钧.硒与冠心病的研究进展[J].微量元素与健康研究,1995,12(1):54-55. 被引量:20
  • 3章净霞,黄萍,徐世文,安丽芝,姚惠英,肖延安,潘巨祥,巢志瑜,朱节清,邹显慷.Zn对细胞保护作用机理的研究[J].生物化学与生物物理进展,1994,21(2):147-150. 被引量:28
  • 4钟福孙 胡文饶 等.硫代巴比妥酸法测定血清过氧化脂质[J].临床检验杂志,1986,4:129-130.
  • 5Yang C Y,Biochemistry,1999年,38卷,15,903页
  • 6赵三妹,中华病理学杂志,1987年,16卷,4期,260页
  • 7钟福孙,临床检验杂志,1986年,4卷,129页

二级参考文献5

共引文献88

同被引文献11

  • 1Ross R. Atherosclerosis is an inflammatory disease[J].{H}American Heart Journal,1999,(5 Pt 2):$419-$420.
  • 2Matsuura E,Hughes GR,Khamashta MA. Oxidation of LDL and its clinical implication[J].{H}Autoimmunity Reviews,2008,(07):558-566.
  • 3Hakkinen T,Karkola K,Yla-Herttuala S. Macrophages,smooth muscle cells,endothelial cells,and T-cells express CI40 and C40L in fatty streaks and more advanced human atheresclerotic lesions:colooalization with epitopes of oxidized low-density lipoprotein,scavenger receptor,and CD16 (Fc gammaRⅢ)[J].{H}VIRCHOWS ARCHIV-AN INTERNATIONAL Journal OF PATHOLOGY,2000,(04):396-405.
  • 4Galis ZS,Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis:the good,the bad,and the ugly[J].{H}CIRCULATION RESEARCH,2002,(03):251-262.
  • 5Ren M,Rajendran R,Ning P. Zinc supplementation decreases the development of atherosclerusis in rabbits[J].{H}Free Radical Biology and Medicine,2006,(02):222-225.
  • 6Sasaki T,Kuzuya M,Nakamura K. AT1 blockade attenuates atherosclerotic plaque.dostabilization accompanied by the suppression of cathepsin S activity in apoE-deficient mice[J].{H}ATHEROSCLEROSIS,2010,(02):430-437.
  • 7Tallman DL,Taylor CG. Effects of dietary fat and zinc on adiposity,serum leptin and adipose fatty acid composition in C57BI_/6J mice[J].{H}Journal of Nutritional Biochemistry,2003,(01):17-23.
  • 8Brown DL,Hibbs MS,Kearney M. Identification of 92-kD gelatinase in human coronary athemsclemtic lesions:association of active enzyme synthesis with unstable angina[J].{H}CIRCULATION,1995,(08):2125-2131.
  • 9Wagsater D,Zhu C,Bjorkegren J. MMP-2 and MMP-9 are prominent matrix metalloproteinases during atherosclemsis development in the Ldlr(-/-)Apob(100/100) mouse[J].{H}International Journal of Molecular Medicine,2011,(02):247-253.
  • 10Namgaladze D,Kollas A,Brune B. Oxidized LDL attenuates apoptosis in monooytic cells by activating ERK signaling[J].{H}Journal of Lipid Research,2008,(01):58-65.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部